Infantile spasms associated with 5-hydroxytryptophan administration in patients with Down's syndrome.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000009:adverse effects*; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D004314:Down Syndrome / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D004569:Electroencephalography; D006801:Humans; D007211:Indoles / Q000097:blood; D007223:Infant; D007231:Infant, Newborn; D011736:Pyridoxine / Q000627:therapeutic use; D012640:Seizures / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology
D007211:Indoles; D000324:Adrenocorticotropic Hormone; D006916:5-Hydroxytryptophan; D011736:Pyridoxine